2004
Gender, Social Support, and Posttraumatic Stress in Postwar Kosovo
Ahern J, Galea S, Fernandez W, Koci B, Waldman R, Vlahov D. Gender, Social Support, and Posttraumatic Stress in Postwar Kosovo. The Journal Of Nervous And Mental Disease 2004, 192: 762-770. PMID: 15505520, DOI: 10.1097/01.nmd.0000144695.02982.41.Peer-Reviewed Original ResearchConceptsPosttraumatic stress scoresPosttraumatic stress symptomsSocial supportStress scoresImportant public health effortsEmergency department studyEmergency department patientsMental health 2 yearsTraumatic eventsPublic health effortsLower posttraumatic stress scoresGreater protective effectStress symptomsLow social supportMore traumatic eventsDepartment patientsHigh prevalenceProtective effectHealth effortsHigher posttraumatic stress scoresDepartment studyMental healthWomenPosttraumatic stressSymptoms
2001
Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy
Semba R, Shah N, Vlahov D. Improvement of Anemia Among HIV-Infected Injection Drug Users Receiving Highly Active Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 26: 315-319. PMID: 11317071, DOI: 10.1097/00126334-200104010-00003.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAnemiaAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBaltimoreBody Mass IndexCD4 Lymphocyte CountChronic DiseaseFemaleHemoglobinsHIV InfectionsHIV-1HumansLongitudinal StudiesMaleMultivariate AnalysisPrevalenceSex FactorsSubstance Abuse, IntravenousViral LoadConceptsInjection drug usersPlasma HIV loadActive antiretroviral therapyAntiretroviral therapyHIV loadOpportunistic infectionsCopies/Mean decreaseDrug usersHIV-positive injection drug usersPotent antiretroviral therapyImprovement of anemiaBody mass indexIncrease of hemoglobinAntiretroviral medicationsHIV infectionMass indexControl subjectsOverall prevalenceChronic diseasesAnemiaNutritional statusMean increaseMultivariate analysisHAARTInitial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men
Sterling T, Vlahov D, Astemborski J, Hoover D, Margolick J, Quinn T. Initial Plasma HIV-1 RNA Levels and Progression to AIDS in Women and Men. New England Journal Of Medicine 2001, 344: 720-725. PMID: 11236775, DOI: 10.1056/nejm200103083441003.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdultAnti-HIV AgentsCD4 Lymphocyte CountDisease ProgressionDisease-Free SurvivalEligibility DeterminationFemaleHIV AntibodiesHIV InfectionsHIV-1HumansLongitudinal StudiesMalePractice Guidelines as TopicRegression AnalysisReverse Transcriptase Polymerase Chain ReactionRiskRNA, ViralSex FactorsViral LoadConceptsInitial viral loadMedian initial viral loadHIV-1 RNAViral loadLymphocyte countHuman immunodeficiency virus type 1 (HIV-1) infectionPlasma HIV-1 RNA levelsHIV-1 RNA levelsHIV-1 RNA copiesFemale injection drug usersVirus type 1 infectionHIV-1 seroconversionMedian initial CD4Risk of progressionHIV-1 infectionType 1 infectionInjection drug usersLikelihood of progressionRate of progressionAntiretroviral therapyInitial CD4Hazard ratioAntiretroviral treatmentTreatment guidelinesImmunodeficiency syndromeCharacteristics of injection drug using parents who retain their children
Pilowsky D, Lyles C, Cross S, Celentano D, Nelson K, Vlahov D. Characteristics of injection drug using parents who retain their children. Drug And Alcohol Dependence 2001, 61: 113-122. PMID: 11137275, DOI: 10.1016/s0376-8716(00)00130-7.Peer-Reviewed Original ResearchConceptsInjection drug usersClinical symptomsHIV-positive parentsActive drug useAge 14High-risk practicesHIV statusInjection drugsRetention of childrenDrug usersDrug useAsymptomatic parentsHealth factorsHIVDrug practicesHealth insuranceChildrenPositive parentsCommunity sampleSymptomsRelated behaviorsParentsIllness
1998
Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk Groups
Lyles C, Vlahov D, Farzadegan H, Astemborski J, Margolick J, Masters B, Schroeder J, Quinn T. Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk Groups. Journal Of Clinical Microbiology 1998, 36: 3647-3652. PMID: 9817889, PMCID: PMC105256, DOI: 10.1128/jcm.36.12.3647-3652.1998.Peer-Reviewed Original ResearchConceptsInfectious viral loadInjection drug usersHIV RNA levelsHIV RNA loadViral loadRisk groupsRNA loadViral burdenHuman immunodeficiency virus type 1 (HIV-1) loadHomosexual menPlasma HIV RNA levelsMale injection drug usersFemale injection drug usersHuman immunodeficiency virus type 1Peripheral blood mononuclear cellsImmunodeficiency virus type 1RNA levelsBlood mononuclear cellsHIV risk groupViral RNA loadVirus type 1HIV loadMononuclear cellsDrug usersCell countSex differences in HIV-1 viral load and progression to AIDS
Farzadegan H, Hoover D, Astemborski J, Lyles C, Margolick J, Markham R, Quinn T, Vlahov D. Sex differences in HIV-1 viral load and progression to AIDS. The Lancet 1998, 352: 1510-1514. PMID: 9820299, DOI: 10.1016/s0140-6736(98)02372-1.Peer-Reviewed Original ResearchConceptsInjection drug usersCD4 cell countProportional hazards modelBranched-chain DNAViral loadQuantitative microcultureReverse transcriptase-PCRPlasma HIV-1 RNA measurementsCell countHIV-1 RNA measurementsUnivariate proportional hazard modelHIV-1 viral loadSame viral loadViral load associationsVisit 3 yearsHIV-1 loadViral load measurementsAntiretroviral therapyAntiretroviral treatmentBaseline visitCommunity clinicsObservational studyHIV-1Current recommendationsHigh riskGender differences in injection-related behaviors among injection drug users in Baltimore, Maryland.
Latkin C, Mandell W, Knowlton A, Doherty M, Vlahov D, Suh T, Celentano D. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Education And Prevention 1998, 10: 257-63. PMID: 9642423.Peer-Reviewed Original ResearchMeSH KeywordsAdultBaltimoreFemaleHIV InfectionsHumansMaleRisk-TakingSex FactorsSubstance Abuse, IntravenousConceptsInjection drug usersDrug usersInjection-related behaviorsMultivariate analysis menHIV protective behaviorsHIV preventive interventionsGender differencesAnalysis menStop AIDSMother's residenceSex networksPreventive interventionsMultivariate analysisBivariate analysisRisk behaviorsBaseline dataWomenProtective behaviorsInterventionInjection behaviorDense personal networksDrug networksResidenceDifferencesSemipublic areas
1997
Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs
Muga R, Roca J, Tor J, Pigem C, Rodriguez R, Egea J, Vlahov D, Muñoz A. Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. International Journal Of STD & AIDS 1997, 8: 225-228. PMID: 9147154, DOI: 10.1258/0956462971919967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusRapid plasma reagentEnzyme-linked immunosorbent assaySerologic syphilisDrug usersSex partnersHigh-risk sexual behaviorCross-sectional analysisGender-specific differencesMale IDUsHIV infectionImmunodeficiency virusFemale IDUsSexual transmissionTreponemal testsReactive samplesSyphilisSexual partnersWestern blotImmunosorbent assayIDUsPlasma reagentWomenSexual behaviorMen
1995
Seroepidemiology of Hepatitis B Virus in a Population of Injecting Drug Users
Levine O, Vlahov D, Koehler J, Cohn S, Spronk A, Nelson K. Seroepidemiology of Hepatitis B Virus in a Population of Injecting Drug Users. American Journal Of Epidemiology 1995, 142: 331-341. PMID: 7631637, DOI: 10.1093/oxfordjournals.aje.a117639.Peer-Reviewed Original ResearchConceptsDrug usersHBV seropositivityHBV seromarkersHepatitis B virus infectionDrug injecting equipmentHigh-risk sexual behaviorB virus infectionHuman immunodeficiency virusInjecting Drug UsersHepatitis B virusHepatitis C virusAfrican American ethnicityHBV transmissionParenteral transmissionHBV infectionImmunodeficiency virusInjecting equipmentSexual transmissionC virusB virusInjecting careerVirus infectionDrug useShooting galleriesStreet outreach
1994
Comparison of clinical manifestations of HIV infection between male and female injecting drug users
Vlahov D, Muñoz A, Solomon L, Astemborski J, Lindsay A, Anderson J, Galai N, Nelson K. Comparison of clinical manifestations of HIV infection between male and female injecting drug users. AIDS 1994, 8: 819-824. PMID: 7916193, DOI: 10.1097/00002030-199406000-00015.Peer-Reviewed Original ResearchConceptsCD4 cell countHIV infectionCell countDrug usersMedian CD4 cell countPosterior cervical lymph nodesAIDS-free HIVHIV-seropositive menCervical lymph nodesHIV-seronegative controlsDiagnosis of AIDSShortness of breathPhysical examination findingsHIV-seropositive participantsSymptoms of diarrheaHIV serologyGenital herpesLymphocyte countLymph nodesMedian ageSimilar CD4Examination findingsClinical manifestationsClinical symptomsConstitutional signsThe Relationships Between Sexual Behavior, Alcohol Use, and Personal Network Characteristics Among Injecting Drug Users in Baltimore, Maryland
LATKIN C, MANDELL W, OZIEMKOWSKA M, VLAHOV D, CELENTANO D. The Relationships Between Sexual Behavior, Alcohol Use, and Personal Network Characteristics Among Injecting Drug Users in Baltimore, Maryland. Sexually Transmitted Diseases 1994, 21: 161-167. PMID: 8073344, DOI: 10.1097/00007435-199405000-00006.Peer-Reviewed Original ResearchComparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users
Schültz C, Vlahov D, Anthony J, Graham N. Comparison of self-reported injection frequencies for past 30 days and 6 months among intravenous drug users. Journal Of Clinical Epidemiology 1994, 47: 191-195. PMID: 8113828, DOI: 10.1016/0895-4356(94)90024-8.Peer-Reviewed Original Research
1993
Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users
Solomon L, Astemborski J, Warren D, Muñoz A, Cohn S, Vlahov D, Nelson K. Differences in Risk Factors for Human Immunodeficiency Virus Type 1 Seroconversion among Male and Female Intravenous Drug Users. American Journal Of Epidemiology 1993, 137: 892-898. PMID: 8484380, DOI: 10.1093/oxfordjournals.aje.a116750.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHuman immunodeficiency virus type 1 (HIV-1) seroconversionDrug usersSeronegative controlsRisk factorsFemale intravenous drug usersMale intravenous drug usersSex-specific risk factorsCurrent intravenous drug useHIV-seronegative controlsIntravenous drug useRisk of seroconversionRisk factor dataCase-control studyAge 18 yearsConditional logistic regression techniquesTime of interviewMore sex partnersSeroconversion statusSeroconversion visitHIV seroconversionHIV infectionStudy entrySexual transmissionSeroconversion
1991
Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilities
1988
Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery
Lillenfeld D, Vlahov D, Tenney J, McLaughlin J. Obesity and diabetes as risk factors for postoperative wound infections after cardiac surgery. American Journal Of Infection Control 1988, 16: 3-6. PMID: 3369746, DOI: 10.1016/0196-6553(88)90003-x.Peer-Reviewed Original ResearchConceptsRelative riskWound infectionRisk factorsControl groupMedian sternotomy wound infectionPostoperative wound infectionIndices of obesityCardiac surgery proceduresSternotomy wound infectionDate of operationPopulation control groupOdds ratio estimatesSecond control groupUndergoing surgeryCardiac surgeryDiabetes mellitusSternotomy infectionsOperative procedureMaryland hospitalsHigh riskSurgery proceduresNursing personnelInfectionEarly signsObesity